Published in Br J Cancer on November 17, 2003
BRAF mutations in hairy-cell leukemia. N Engl J Med (2011) 7.05
Expression of endogenous oncogenic V600EB-raf induces proliferation and developmental defects in mice and transformation of primary fibroblasts. Cancer Res (2005) 1.93
Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response. Oncotarget (2012) 1.85
Impact of feedback phosphorylation and Raf heterodimerization on normal and mutant B-Raf signaling. Mol Cell Biol (2009) 1.81
Selective Raf inhibition in cancer therapy. Expert Opin Ther Targets (2007) 1.44
Germinal center B cell-like (GCB) and activated B cell-like (ABC) type of diffuse large B cell lymphoma (DLBCL): analysis of molecular predictors, signatures, cell cycle state and patient survival. Cancer Inform (2007) 1.03
Expression of sprouty2 inhibits B-cell proliferation and is epigenetically silenced in mouse and human B-cell lymphomas. Blood (2009) 1.03
Targeting the RAF/MEK/ERK, PI3K/AKT and p53 pathways in hematopoietic drug resistance. Adv Enzyme Regul (2007) 1.01
Identification of cancer-associated gene clusters and genes via clustering penalization. Stat Interface (2009) 0.96
Utilizing protein structure to identify non-random somatic mutations. BMC Bioinformatics (2013) 0.96
A critical function for B-Raf at multiple stages of myelopoiesis. Blood (2005) 0.92
A spatial simulation approach to account for protein structure when identifying non-random somatic mutations. BMC Bioinformatics (2014) 0.83
Hematopoietic expression of oncogenic BRAF promotes aberrant growth of monocyte-lineage cells resistant to PLX4720. Mol Cancer Res (2013) 0.79
Thyroid carcinoma-associated genetic mutations also occur in thyroid lymphomas. Mod Pathol (2012) 0.75
Mutations of the BRAF gene in human cancer. Nature (2002) 65.42
ras oncogenes in human cancer: a review. Cancer Res (1989) 22.03
A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood (1994) 21.00
Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer (2003) 15.17
High frequency of BRAF mutations in nevi. Nat Genet (2002) 9.95
BRAF and RAS mutations in human lung cancer and melanoma. Cancer Res (2002) 8.55
Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature (2002) 7.46
Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia. Cancer Res (2002) 4.46
Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation. Cancer Res (2003) 4.03
Missense mutations of the BRAF gene in human lung adenocarcinoma. Cancer Res (2002) 2.48
A simple, precise and economical microdissection technique for analysis of genomic DNA from archival tissue sections. Virchows Arch (1998) 1.12
The pattern of mutational involvement of RAS genes in human hematologic malignancies determined by DNA amplification and direct sequencing. Blood (1990) 1.08
Alterations of Fas (Apo-1/CD95) gene in cutaneous malignant melanoma. Am J Pathol (1999) 0.98
Three-dimensional tertiary structure of yeast phenylalanine transfer RNA. Science (1974) 11.02
A receptor kinase-like protein encoded by the rice disease resistance gene, Xa21. Science (1995) 9.79
Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nat Med (1998) 8.62
Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet (2000) 7.39
Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature (1995) 6.85
Saturated molecular map of the rice genome based on an interspecific backcross population. Genetics (1994) 6.22
Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci U S A (1996) 5.94
RXR beta: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell (1991) 5.89
Molecular switch for signal transduction: structural differences between active and inactive forms of protooncogenic ras proteins. Science (1990) 5.76
Four-helical-bundle structure of the cytoplasmic domain of a serine chemotaxis receptor. Nature (1999) 5.38
Notch1 expression in early lymphopoiesis influences B versus T lineage determination. Immunity (1999) 5.34
Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol (1997) 5.33
Identification of mycobacterial species by comparative sequence analysis of the RNA polymerase gene (rpoB). J Clin Microbiol (1999) 5.28
Crystal structure of cyclin-dependent kinase 2. Nature (1993) 5.21
ABFs, a family of ABA-responsive element binding factors. J Biol Chem (2000) 4.98
Three-dimensional structures of the ligand-binding domain of the bacterial aspartate receptor with and without a ligand. Science (1991) 4.71
Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy. Proc Natl Acad Sci U S A (2009) 4.58
Natural genetic transformation of Streptococcus mutans growing in biofilms. J Bacteriol (2001) 4.50
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study. Leukemia (2011) 4.47
Crystal structure of the ATP-binding subunit of an ABC transporter. Nature (1998) 4.47
Phylogenetic affiliation of the pseudomonads based on 16S rRNA sequence. Int J Syst Evol Microbiol (2000) 4.31
Three-dimensional structure of yeast phenylalanine transfer RNA: folding of the polynucleotide chain. Science (1973) 4.31
The general structure of transfer RNA molecules. Proc Natl Acad Sci U S A (1974) 4.30
Tomato Prf is a member of the leucine-rich repeat class of plant disease resistance genes and lies embedded within the Pto kinase gene cluster. Cell (1996) 4.29
Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell (1995) 4.17
Electron transfer by domain movement in cytochrome bc1. Nature (1998) 4.08
Crystal structure of a small heat-shock protein. Nature (1998) 4.07
The joining of ribosomal subunits in eukaryotes requires eIF5B. Nature (2000) 4.01
Antibacterial agents based on the cyclic D,L-alpha-peptide architecture. Nature (2001) 4.00
Three-dimensional structure of an oncogene protein: catalytic domain of human c-H-ras p21. Science (1988) 3.99
Genetic and pharmacological suppression of oncogenic mutations in ras genes of yeast and humans. Science (1989) 3.90
Molecular characterization of a neuronal low-voltage-activated T-type calcium channel. Nature (1998) 3.77
Differential distribution of three members of a gene family encoding low voltage-activated (T-type) calcium channels. J Neurosci (1999) 3.73
Sequential folding of transfer RNA. A nuclear magnetic resonance study of successively longer tRNA fragments with a common 5' end. J Mol Biol (1980) 3.63
alpha-Synuclein gene duplication is present in sporadic Parkinson disease. Neurology (2007) 3.62
Quantitative mRNA expression analysis from formalin-fixed, paraffin-embedded tissues using 5' nuclease quantitative reverse transcription-polymerase chain reaction. J Mol Diagn (2000) 3.59
Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors. Science (1998) 3.53
Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial. Ann Intern Med (1994) 3.53
Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc. EMBO J (1999) 3.50
Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem (2000) 3.45
Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity (1999) 3.43
Crystal structure of yeast phenylalanine transfer RNA. II. Structural features and functional implications. J Mol Biol (1978) 3.41
Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen. J Neurosci (2000) 3.40
Evolution of sensory complexity recorded in a myxobacterial genome. Proc Natl Acad Sci U S A (2006) 3.35
Bronchoscopic assessment of the evolution of endobronchial tuberculosis. Chest (2000) 3.24
Frzb-1 is a secreted antagonist of Wnt signaling expressed in the Spemann organizer. Cell (1997) 3.23
Crystal structure of yeast phenylalanine transfer RNA. I. Crystallographic refinement. J Mol Biol (1978) 3.19
In vitro selection of zinc fingers with altered DNA-binding specificity. Biochemistry (1994) 3.18
Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int (2007) 3.17
Quantitative analysis of total macrophage content in adult mouse tissues. Immunochemical studies with monoclonal antibody F4/80. J Exp Med (1985) 3.11
Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat Med (2001) 3.07
Germline and somatic transformation of mating Tetrahymena thermophila by particle bombardment. Genetics (1997) 3.04
Survey of extended-spectrum beta-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence of TEM-52 in Korea. J Clin Microbiol (1999) 3.04
Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain. J Biol Chem (1987) 3.04
Cloning and expression of a cardiac/brain beta subunit of the L-type calcium channel. J Biol Chem (1992) 3.03
A new dynamin-like protein, ADL6, is involved in trafficking from the trans-Golgi network to the central vacuole in Arabidopsis. Plant Cell (2001) 3.01
Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc Natl Acad Sci U S A (1997) 2.99
Distinct molecular mechanisms and divergent endocytotic pathways of AMPA receptor internalization. Nat Neurosci (2000) 2.99
Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria. Oncogene (2006) 2.96
Analysis of upstream elements in the HuC promoter leads to the establishment of transgenic zebrafish with fluorescent neurons. Dev Biol (2000) 2.93
The combination of bedside swallowing assessment and oxygen saturation monitoring of swallowing in acute stroke: a safe and humane screening tool. Age Ageing (2000) 2.92
Deficient neurogenesis in forebrain-specific presenilin-1 knockout mice is associated with reduced clearance of hippocampal memory traces. Neuron (2001) 2.92
B cell differentiation and isotype switching is related to division cycle number. J Exp Med (1996) 2.90
Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim Biophys Acta (1987) 2.90
The prevalence of premature ejaculation and its clinical characteristics in Korean men according to different definitions. Int J Impot Res (2012) 2.88
Burn wound infections: current status. World J Surg (1998) 2.86
Three-dimensional structure of yeast phenylalanine transfer RNA at 3.0angstroms resolution. Nature (1974) 2.85
Ultrafast bond softening in bismuth: mapping a solid's interatomic potential with X-rays. Science (2007) 2.84
Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain. Pain (1994) 2.80
RNA-ligant interactions. (I) Magnesium binding sites in yeast tRNAPhe. Nucleic Acids Res (1977) 2.79
Different clinical features of aortic intramural hematoma versus dissection involving the ascending aorta. J Am Coll Cardiol (2001) 2.77
Accuracy of magnetic resonance imaging in determining cause of sudden death in adults: comparison with conventional autopsy. Histopathology (2003) 2.75
Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases. Immunity (1995) 2.74
Localization of a gene for partial epilepsy to chromosome 10q. Nat Genet (1995) 2.72
Iodine-123 MIBG imaging before treatment of heart failure with carvedilol to predict improvement of left ventricular function and exercise capacity. J Nucl Cardiol (2001) 2.70
Structure-based assignment of the biochemical function of a hypothetical protein: a test case of structural genomics. Proc Natl Acad Sci U S A (1998) 2.70
The in vitro replication of DNA containing the SV40 origin. J Biol Chem (1990) 2.68
PRMT5 (Janus kinase-binding protein 1) catalyzes the formation of symmetric dimethylarginine residues in proteins. J Biol Chem (2001) 2.67
Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem Biophys Res Commun (1998) 2.67
Long-term metformin use reduces gastric cancer risk in type 2 diabetics without insulin treatment: a nationwide cohort study. Aliment Pharmacol Ther (2014) 2.66
Crystal structure of an RNA double helix incorporating a track of non-Watson-Crick base pairs. Nature (1991) 2.65
Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine. Eur J Biochem (1997) 2.65
BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy. Clin Cancer Res (2001) 2.64
DNA sequences of structural genes for Eco RI DNA restriction and modification enzymes. J Biol Chem (1981) 2.63
Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord. J Neurosci (1995) 2.62
NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis. Am J Med (1994) 2.60
Inactivation of the Porphyromonas gingivalis fimA gene blocks periodontal damage in gnotobiotic rats. J Bacteriol (1994) 2.59
High-level expression of M13 gene II protein from an inducible polycistronic messenger RNA. Gene (1985) 2.56
Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther (2004) 2.55
Risk of death from intercurrent disease is not excessively increased by modern postoperative radiotherapy for high-risk resected non-small-cell lung carcinoma. J Clin Oncol (2001) 2.55
Viral kinetics in patients with chronic hepatitis C treated with standard or peginterferon alpha2a. Gastroenterology (2001) 2.53
Reproductive and neonatal losses associated with possible encephalomyocarditis virus infection in pigs. Vet Rec (1990) 2.52
Tremorgenic indole alkaloids potently inhibit smooth muscle high-conductance calcium-activated potassium channels. Biochemistry (1994) 2.51
Incorporation of adenovirus in calcium phosphate precipitates enhances gene transfer to airway epithelia in vitro and in vivo. J Clin Invest (1998) 2.51
Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas. Nat Genet (1998) 2.50
Cloning and characterization of alpha1H from human heart, a member of the T-type Ca2+ channel gene family. Circ Res (1998) 2.49
Idiopathic transverse myelitis: MR characteristics. AJNR Am J Neuroradiol (1996) 2.48
Association of the metabolic syndrome with intracranial atherosclerotic stroke. Neurology (2005) 2.45
Clp P represents a unique family of serine proteases. J Biol Chem (1990) 2.42
PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction. Kidney Int (2001) 2.41